99 related articles for article (PubMed ID: 26591164)
1. Higher Incidence of Pulmonary Hypertension in Antiphospholipid Antibody Positive Lupus.
Ware D; Sharma V; Kalekar L; Kamble A; Mahajan A; Gokhale Y
J Assoc Physicians India; 2015 Apr; 63(4):17-20. PubMed ID: 26591164
[TBL] [Abstract][Full Text] [Related]
2. Antiphospholipid antibodies can identify lupus patients at risk of pulmonary hypertension: A systematic review and meta-analysis.
Zuily S; Domingues V; Suty-Selton C; Eschwège V; Bertoletti L; Chaouat A; Chabot F; Regnault V; Horn EM; Erkan D; Wahl D
Autoimmun Rev; 2017 Jun; 16(6):576-586. PubMed ID: 28411166
[TBL] [Abstract][Full Text] [Related]
3. [Antiphospholipid syndrome and stroke].
Kitagawa Y
Rinsho Shinkeigaku; 2005 Nov; 45(11):852-5. PubMed ID: 16447744
[TBL] [Abstract][Full Text] [Related]
4. Antiphospholipid antibodies in children with systemic lupus erythematosus: a prospective study in northern India.
Ahluwalia J; Singh S; Garewal G
Rheumatol Int; 2005 Sep; 25(7):530-5. PubMed ID: 15338189
[TBL] [Abstract][Full Text] [Related]
5. Vascular endothelial growth factor, lipoporotein-associated phospholipase A2, sP-selectin and antiphospholipid antibodies, biological markers with prognostic value in pulmonary hypertension associated with chronic obstructive pulmonary disease and systemic lupus erithematosus.
Tanaseanu C; Tudor S; Tamsulea I; Marta D; Manea G; Moldoveanu E
Eur J Med Res; 2007 Apr; 12(4):145-51. PubMed ID: 17509958
[TBL] [Abstract][Full Text] [Related]
6. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and clinical associations of lupus anticoagulant, anticardiolipin antibodies, and anti-beta2-glycoprotein I antibodies in patients with systemic lupus erythematosus.
Woo KS; Kim KE; Kim JM; Han JY; Chung WT; Kim KH
Korean J Lab Med; 2010 Feb; 30(1):38-44. PubMed ID: 20197721
[TBL] [Abstract][Full Text] [Related]
8. Pulmonary hypertension in systemic lupus erythematosus: relationship with antiphospholipid antibodies and severe disease outcome.
Cefle A; Inanc M; Sayarlioglu M; Kamali S; Gul A; Ocal L; Aral O; Konice M
Rheumatol Int; 2011 Feb; 31(2):183-9. PubMed ID: 20012052
[TBL] [Abstract][Full Text] [Related]
9. Significance of antiphospholipid antibodies in lupus nephritis.
Natejumnong C; Ruangkanchanasetr P; Aimpun P; Supaporn T
J Med Assoc Thai; 2006 Aug; 89 Suppl 2():S121-8. PubMed ID: 17044463
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of antibodies to beta2-glycoprotein I in systemic lupus erythematosus and their association with antiphospholipid antibody syndrome criteria: a single center study and literature review.
Bruce IN; Clark-Soloninka CA; Spitzer KA; Gladman DD; Urowitz MB; Laskin CA
J Rheumatol; 2000 Dec; 27(12):2833-7. PubMed ID: 11128672
[TBL] [Abstract][Full Text] [Related]
11. Study of audiovestibular dysfunction in children with systemic lupus erythematosus.
Gad GI; Mohamed ST; Awwad KS; Mohamed RF
Int J Pediatr Otorhinolaryngol; 2013 Sep; 77(9):1561-6. PubMed ID: 23916731
[TBL] [Abstract][Full Text] [Related]
12. Determinants of risk for venous and arterial thrombosis in primary antiphospholipid syndrome and in antiphospholipid syndrome with systemic lupus erythematosus.
Danowski A; de Azevedo MN; de Souza Papi JA; Petri M
J Rheumatol; 2009 Jun; 36(6):1195-9. PubMed ID: 19447935
[TBL] [Abstract][Full Text] [Related]
13. Pulmonary arterial hypertension in SLE: what do we know?
Prabu A; Gordon C
Lupus; 2013 Oct; 22(12):1274-85. PubMed ID: 24098000
[TBL] [Abstract][Full Text] [Related]
14. Antiphospholipid antibodies in children with systemic lupus erythematosus: a long-term clinical and laboratory follow-up status study from northwest India.
Ahluwalia J; Singh S; Naseem S; Suri D; Rawat A; Gupta A; Masih J; Bose S
Rheumatol Int; 2014 May; 34(5):669-73. PubMed ID: 23563494
[TBL] [Abstract][Full Text] [Related]
15. Autoantibodies to beta2-glycoprotein I in systemic lupus erythematosus and primary antiphospholipid antibody syndrome: clinical correlations in comparison with other antiphospholipid antibody tests.
Day HM; Thiagarajan P; Ahn C; Reveille JD; Tinker KF; Arnett FC
J Rheumatol; 1998 Apr; 25(4):667-74. PubMed ID: 9558167
[TBL] [Abstract][Full Text] [Related]
16. [Antibodies to various phospholipids in SLE patients with primary antiphospholipid syndrome].
Reshetniak TM; Boĭtsekhovskaia B; Alekberova ZS; Kalashnikova LA; Mach ES; Zabek Ia
Klin Med (Mosk); 1999; 77(5):32-7. PubMed ID: 10394784
[TBL] [Abstract][Full Text] [Related]
17. Lupus anticoagulant, high levels of anticardiolipin, and anti-beta2-glycoprotein I antibodies are associated with chronic thromboembolic pulmonary hypertension.
Martinuzzo ME; Pombo G; Forastiero RR; Cerrato GS; Colorio CC; Carreras LO
J Rheumatol; 1998 Jul; 25(7):1313-9. PubMed ID: 9676762
[TBL] [Abstract][Full Text] [Related]
18. The relationship of antiphospholipid antibodies to thromboembolic events in pediatric patients with systemic lupus erythematosus: a cross-sectional study.
Berube C; Mitchell L; Silverman E; David M; Saint Cyr C; Laxer R; Adams M; Vegh P; Andrew M
Pediatr Res; 1998 Sep; 44(3):351-6. PubMed ID: 9727712
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of antiphospholipid antibodies in patients with subacute and chronic cutaneous lupus erythematosus.
García-Martín P; García-García C; Fraga J; García-Díez A
Actas Dermosifiliogr; 2013 Apr; 104(3):232-8. PubMed ID: 23332556
[TBL] [Abstract][Full Text] [Related]
20. Thrombin generation measured ex vivo following microvascular injury is increased in SLE patients with antiphospholipid-protein antibodies.
Musiał J; Swadźba J; Jankowski M; Grzywacz M; Bazan-Socha S; Szczeklik A
Thromb Haemost; 1997 Oct; 78(4):1173-7. PubMed ID: 9364980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]